Clinical Trial Update: Data Analysis of Adult and Pediatric Participants With Acid Sphingomyelinase Deficiency (ASMD) on Early Access to Olipudase Alfa in France

View source ↗

Summary

This document reports a completed data analysis of adult and pediatric participants with acid sphingomyelinase deficiency (ASMD) who received early access to ol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acid Sphingomyelinase Deficiency

Drugs mentioned

• Xenpozyme (olipudase alfa) (olipudase alfa)

Snippet

Sponsor: Sanofi | Conditions: Acid Sphingomyelinase Deficiency (ASMD) | Status: COMPLETED